Schedule Dispatches

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

February 2025

New Listings

• Atorvastatin (Lorstat) tab 10 mg (p’code 2697580) and tab 80 mg (p’code 2697599), 30 tab packs
• Bee venom allergy treatment (VENOX) initiation kit – 1 vial freeze dried venom with diluent, 1 OP – Special Authority – Retail pharmacy, s29 (p’code 2698773)
• Carboplatin (DBL Carboplatin S29) inj 10 mg per ml, 45 ml vial – PCT only – Specialist, s29 (p’code 2698943)
• Clomipramine hydrochloride (APO Clomipramine) tab 25 mg – Safety medicine (p’code 2565773)
• Denosumab (Xgeva) inj 120 mg per 1.7 ml vial – Special Authority – Retail pharmacy (p’code 2594870)
• Diclofenac sodium (Diclofenac Devatis) eye drops 0.1%, single dose, 10 dose (p’code 2694360) and 30 dose (p’code 2694352)
• Efavirenz with emtricitabine and tenofovir disoproxil (Triovir) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate) – Special Authority – Retail pharmacy, s29 and wastage claimable (p’code 2698935)
• Entacapone (Entapone) tab 200 mg (p’code 2685299)
• Fexofenadine hydrochloride (Fexaclear) tab 120 mg (p’code 2698781) and tab 180 mg (p’code 2697092)
• Itraconazole (Itracap) cap 100 mg – s29 and wastage claimable (p’code 2698560)
• Levodopa with carbidopa and entacapone (Stalevo) tab 50 mg with carbidopa 12.5 mg and entacapone 200 mg (p’code 2696533), tab 100 mg with carbidopa 25 mg and entacapone 200 mg (p’code 2696541), tab 150 mg with carbidopa 37.5 mg and entacapone 200 mg (p’code 2696568) and tab 200 mg with carbidopa 50 mg and entacapone 200 mg (p’code 2696576)

Changes to restrictions, chemical names and presentations

• Denosumab inj 60 mg prefilled syringe (Prolia) and inj 120 mg per 1.7 ml vial (Xgeva) – added note and amended Special Authority criteria
• Ezetimibe (Ezemibe and Ezetimibe Sandoz) tab 10 mg – reinstate stat dispensing
• High fat low carbohydrate formula powder (unflavoured), 300 g OP (KetoCal 4:1 and Ketocal 3:1) and powder (vanilla), 300 g OP (KetoCal 4:1) – addition of Hospital pharmacy [HP3] rule
• Midazolam (Midazolam-Baxter) inj 5 mg per ml, 3 ml ampoule – removal of brand switch fee
• Oxycodone hydrochloride (Oxycodone Lucis) oral liq 1 mg per ml, 250 ml – removal of s29 and wastage claimable
• Pazopanib (Pazopanib Teva and Votrient) tab 200 mg and 400 mg – amended Special Authority criteria
• Preservative Free Ocular Lubricants – amended Special Authority criteria
• Sunitinib (Sunitinib Pfizer) cap 12.5 mg, 25 mg and 50 mg – amended Special Authority criteria

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Antithymocyte globulin (equine)	Inj 50 mg per ml, 5 ml	ATGAM
Benzathine benzylpenicillin	Inj 900 mg (1.2 million units) in 2.3 ml syringe	Bicillin LA
Cyproterone acetate	Tab 50 mg and 100 mg	Siterone
Dantrolene	Cap 25 mg	Dantrium S29
Desferrioxamine mesilate	Inj 500 mg vial	DBL Desferrioxamine Mesylate for Inj BP
Heparin sodium	Inj 25,000 iu per ml, 0.2 ml	Hospira
Hydroxocobalamin	Inj 1 mg per ml, 1 ml ampoule	Hydroxocobalamin Panpharma
Medroxyprogesterone acetate	Inj 150 mg per ml, 1 ml syringe	Depo-Provera
Methotrexate	Inj 2.5 mg per ml, 2 ml	Methotrexate DBL
Methylprednisolone (as sodium succinate)	Inj 500 mg vial Inj 1 g vial	Solu-Medrol-Act-O-Vial Solu-Medrol
Salbutamol	Aerosol inhaler, 100 mcg per dose CFC free, 200 dose OP	SalAir
Sulfasalazine	Tab 500 mg Tab EC 500 mg	Salazopyrin Salazopyrin EN

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Cisplatin	Inj 1 mg for ECP	Baxter